BPHA – Session #7 – The Pharmaceutical Industry, Reimbursement and Public-Private Sustainability

BPHA – Session #7 – The Pharmaceutical Industry, Reimbursement and Public-Private Sustainability

This session has three modules. Modules in this session dig deeper into the important pharmaceutical and drug plan issues of today, public and private. You will learn about the process of prescription drug development, market launch and patent protection, including how specialty drugs have changed the reimbursement landscape, the complexities of brand and generic and the impact of changes in drug pricing on access. Instructors will also address drug plan formulary management and how electronic claims adjudication has changed the way drug benefits are managed. Finally, you will explore the affordability in the public and private sector world of prescription drugs, including the developing discussion on pharmacare. At the end of this session you will know much more than the average benefits professional about prescription drug development, pricing, reimbursement and affordability issues and you will understand to what extent public drug programs can be a viable option in the future.

Price: $50.00 (plus applicable federal and provincial taxes)